IRMD - IRadimed Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
35,966
30,439
23,082
32,497
31,594
Cost of Revenue
8,057
7,212
5,570
6,155
5,840
Gross Profit
27,909
23,227
17,512
26,342
25,753
Operating Expenses
Research Development
1,421
1,517
1,723
1,348
1,764
Selling General and Administrative
18,287
15,706
14,504
14,074
12,476
Total Operating Expenses
19,708
17,224
16,227
15,422
14,240
Operating Income or Loss
8,201
6,004
1,285
10,920
11,513
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
126
-45
-11
-94
121
Income Before Tax
8,565
6,197
1,396
10,953
11,635
Income Tax Expense
469
-106
897
3,738
4,105
Income from Continuing Operations
8,096
6,303
500
7,215
7,530
Net Income
8,096
6,303
500
7,215
7,530
Net Income available to common shareholders
8,096
6,303
500
7,215
7,530
Reported EPS
Basic
-
0.59
0.05
0.67
0.68
Diluted
-
0.52
0.04
0.60
0.60
Weighted average shares outstanding
Basic
-
10,759
10,639
10,818
11,003
Diluted
-
12,110
11,720
11,990
12,557
EBITDA
-
7,109
2,594
11,168
11,737